Bookish ProsePublications

Publications

2010. “Strategies for Opioid Rotation: Decision Support in Chronic Pain Management” Medscape, March. http://cme.medscape.com/viewarticle/717832

2010. “Clinical Implications of Opioid Pharmacogenetics” Clinical Journal of Pain 26:(suppl 10) S16-S20.

2009. IL-6 and insulin resistance, in Insulin and IGFs, Academic Press, Elsevier. Vitamins & Hormones 80: 613-633.

2008. “Management of Expected and Unexpected Opioid-related Side Effects” Clinical Journal of Pain 24: (suppl 10) S8-S13.

2007. “Topical Agents for the Management of Neuropathic and Musculoskeletal Pain” Journal of Pain and Symptom Management 33: 342-355.

2006. “Promoting Adherence to Bipolar Disorder Treatment Regimens” CME Newsletter.

2006. “A Nuclear Transport Signal in Mammalian Target of Rapamycin is Critical for its Cytoplasmic Signaling” JBC 281: 7357-7363.

2005. “Chronic Pain Management in the Elderly: Linking Mechanisms & Guidelines to the Realities of Clinical Practice” Geriatrics (suppl) Nov.

2004. “The Role of Biologics in the Evolving Treatment Paradigm for Psoriasis” Dermatology Times 30: (suppl 5).

2002. “Regulation of Ribosomal S6 Kinase 2 by Mammalian Target of Rapamycin” JBC277: 31423-31429.

2001. “Phosphatidic acid-mediated mitogenic activation of mTOR signaling” Science294: 1942-1945.

2010. “DYS-HAC-iPS Cells: The Combination of Gene and Cell Therapy to Treat Duchenne Muscular Dystrophy.” Molecular Therapy 18: 238–240.

2008. “Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?” NCP Cardio Med 5: S10.

2007. “Ablative techniques for the management of kidney cancer” NCP Uro 4:261-269.

“Structural Requirements for Subcellular Localization, Signaling Activity, and Catalytic Activity of FRAP.” Cold Spring Harbor Labs, fall 2000